Date | Dividends Paid | Capital Expenditure | Other Financing Activities | Net Cash Used Provided By Financing Activities |
---|
CEO | Mr. Konrad Palka |
IPO Date | Aug. 1, 2008 |
Location | Poland |
Headquarters | ul. Wólczanska 178 |
Employees | 15 |
Sector | Consumers Staples |
Industries |
Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including skin, hair, and nail care products, as well as dietary supplement for atherosclerosis prophylaxis. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. The company is developing 1-MNA, an anti-atherosclerosis drug which is under phase II clinical trial. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. is a subsidiary of Pelion S.A.
Past 5 years
StockViz Staff
February 6, 2025
Any question? Send us an email